Early detection of pancreatic cancer using fluid from the upper gut
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study collects fluid from the first part of the small intestine (duodenum) during an endoscopy to see if it can help detect pancreatic cancer early. It is for people who already need an endoscopy for medical reasons.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You are already scheduled for an upper endoscopy, endoscopic ultrasound, or ERCP as part of your medical care.
- You have either been diagnosed with pancreatic ductal adenocarcinoma (stage I–IV) OR imaging suggests you may have pancreatic cancer and you are scheduled for a biopsy.
- If you do not have pancreatic cancer, you may have a pancreatic cyst or pancreatitis, or you have no known pancreatic disease.
- You must be medically stable and able to undergo endoscopy safely.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “tumor regulatory molecules,” which are substances that may be released by cancer, to improve early pancreatic cancer detection. You may join if you have early, localized pancreatic cancer that can be treated with surgery, or certain pancreatic cysts/fluid collections where doctors are investigating further.
This study tests LINFU™, a noninvasive method to collect pancreatic cells to help detect pancreatic cancer earlier. You may be invited if you’re at higher risk or you have concerning symptoms and planned pancreas/bile testing (like EUS or CT).
This study uses blood taken from a vein to build and check diagnostic models for pancreatic cancer. It may help doctors identify pancreatic cancer more accurately in people who have a suspected mass on imaging.
This study tests a new lab test called PanCystPro that looks at fluid taken from a pancreatic cyst during an endoscopic ultrasound. It aims to help doctors better manage your condition.
This study looks at how certain substances in your blood and bacteria in your gut might help predict pancreatic cancer, especially in people with chronic pancreatitis. It aims to find early warning signs to catch cancer sooner.
This study tests a new imaging procedure called LINFU® that may help doctors better detect pancreatic cancer. You may join if you have symptoms or an abnormal scan that suggests pancreatic cancer, and you're scheduled for a biopsy.
Hear when a new Pancreatic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.